Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. [electronic resource]
Producer: 20160112Description: 1283-92 p. digitalISSN:- 1600-6143
- Adult
- Aged
- Biopsy
- Enzyme Inhibitors -- administration & dosage
- Female
- Glomerular Filtration Rate
- Graft Rejection
- Humans
- Immunosuppressive Agents -- administration & dosage
- Incidence
- Kaplan-Meier Estimate
- Kidney Transplantation
- Liver Failure -- mortality
- Liver Transplantation -- methods
- Male
- Middle Aged
- Protein Kinase C -- antagonists & inhibitors
- Pyrroles -- administration & dosage
- Quinazolines -- administration & dosage
- Tacrolimus -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.